{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T01:19:37Z","timestamp":1790558377140,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T00:00:00Z","timestamp":1579478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T00:00:00Z","timestamp":1579478400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Reactivation of the anti-tumor response has shown substantial progress in aggressive tumors such as melanoma and lung cancer. Data on less common histotypes are scanty. Immune checkpoint inhibitor therapy has been applied to few cases of uterine leiomyosarcomas, of which the immune cell composition was not examined in detail. We analyzed the inflammatory infiltrate of 21 such cases in high-dimensional, single cell phenotyping on routinely processed tissue. T-lymphoid cells displayed a composite phenotype common to all tumors, suggestive of antigen-exposure, acute and chronic exhaustion. To the contrary, myelomonocytic cells had case-specific individual combinations of phenotypes and subsets. We identified five distinct monocyte-macrophage cell types, some not described before, bearing immunosuppressive molecules (TIM3, B7H3, VISTA, PD1, PDL1). Detailed <jats:italic>in situ<\/jats:italic> analysis of routinely processed tissue yields comprehensive information about the immune status of sarcomas. The method employed provides equivalent information to extractive single-cell technology, with spatial contexture and a modest investment.<\/jats:p>","DOI":"10.1038\/s41598-020-57627-1","type":"journal-article","created":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T11:03:40Z","timestamp":1579518220000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["The Adaptive and Innate Immune Cell Landscape of Uterine Leiomyosarcomas"],"prefix":"10.1038","volume":"10","author":[{"given":"Marco","family":"Manzoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena M.","family":"Bolognesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asier","family":"Antoranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Mancari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvestro","family":"Carinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Faretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca M.","family":"Bosisio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3799-3221","authenticated-orcid":false,"given":"Giorgio","family":"Cattoretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,20]]},"reference":[{"key":"57627_CR1","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nrg1944","volume":"7","author":"P Gregersen","year":"2006","unstructured":"Gregersen, P. & Behrens, T. Genetics of autoimmune diseases\u2013disorders of immune homeostasis. Nat. Rev. Genet. 7, 917\u2013928, https:\/\/doi.org\/10.1038\/nrg1944 (2006).","journal-title":"Nat. Rev. Genet."},{"key":"57627_CR2","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/S0140-6736(13)62226-6","volume":"383","author":"D Hanahan","year":"2014","unstructured":"Hanahan, D. Rethinking the war on cancer. Lancet 383, 558\u2013563, https:\/\/doi.org\/10.1016\/S0140-6736(13)62226-6 (2014).","journal-title":"Lancet"},{"key":"57627_CR3","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature21349","volume":"541","author":"DS Chen","year":"2017","unstructured":"Chen, D. S. & Mellman, I. Elements of cancer immunity and the cancer-immune set point. Nature 541, 321\u2013330, https:\/\/doi.org\/10.1038\/nature21349 (2017).","journal-title":"Nature"},{"key":"57627_CR4","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.cell.2016.01.049","volume":"164","author":"AK Palucka","year":"2016","unstructured":"Palucka, A. K. & Coussens, L. M. The Basis of Oncoimmunology. Cell. 164, 1233\u20131247, https:\/\/doi.org\/10.1016\/j.cell.2016.01.049 (2016).","journal-title":"Cell"},{"key":"57627_CR5","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/515496a","volume":"515","author":"JD Wolchok","year":"2014","unstructured":"Wolchok, J. D. & Chan, T. A. Cancer: Antitumour immunity gets a boost. Nature 515, 496\u2013498, https:\/\/doi.org\/10.1038\/515496a (2014).","journal-title":"Nature"},{"key":"57627_CR6","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","volume":"27","author":"SL Topalian","year":"2015","unstructured":"Topalian, S. L., Drake, C. G. & Pardoll, D. M. Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy. Cancer Cell. 27, 450\u2013461, https:\/\/doi.org\/10.1016\/j.ccell.2015.03.001 (2015).","journal-title":"Cancer Cell"},{"key":"57627_CR7","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1126\/science.aaf2834","volume":"352","author":"CU Blank","year":"2016","unstructured":"Blank, C. U., Haanen, J. B., Ribas, A. & Schumacher, T. N. CANCER IMMUNOLOGY. The \u201ccancer immunogram\u201d. Science 352, 658\u2013660, https:\/\/doi.org\/10.1126\/science.aaf2834 (2016).","journal-title":"Science"},{"key":"57627_CR8","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1126\/science.aaa6204","volume":"348","author":"JA Joyce","year":"2015","unstructured":"Joyce, J. A. & Fearon, D. T. T cell exclusion, immune privilege, and the tumor microenvironment. Science 348, 74\u201380, https:\/\/doi.org\/10.1126\/science.aaa6204 (2015).","journal-title":"Science"},{"key":"57627_CR9","doi-asserted-by":"publisher","first-page":"E10119","DOI":"10.1073\/pnas.1802166115","volume":"115","author":"M Kowanetz","year":"2018","unstructured":"Kowanetz, M. et al. Differential regulation of PD-L1 expression by immune and tumor cells in NSCLC and the response to treatment with atezolizumab (anti-PD-L1). Proc. Natl. Acad. Sci. USA 115, E10119\u2013E10126, https:\/\/doi.org\/10.1073\/pnas.1802166115 (2018).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"57627_CR10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1126\/science.aaa4971","volume":"348","author":"TN Schumacher","year":"2015","unstructured":"Schumacher, T. N. & Schreiber, R. D. Neoantigens in cancer immunotherapy. Science 348, 69\u201374, https:\/\/doi.org\/10.1126\/science.aaa4971 (2015).","journal-title":"Science"},{"key":"57627_CR11","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1056\/NEJMe1205943","volume":"366","author":"A Ribas","year":"2012","unstructured":"Ribas, A. Tumor immunotherapy directed at PD-1. N. Engl. J. Med. 366, 2517\u20132519, https:\/\/doi.org\/10.1056\/NEJMe1205943 (2012).","journal-title":"N. Engl. J. Med."},{"key":"57627_CR12","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1126\/science.aaa1348","volume":"348","author":"NA Rizvi","year":"2015","unstructured":"Rizvi, N. A. et al. Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. Science 348, 124\u2013128, https:\/\/doi.org\/10.1126\/science.aaa1348 (2015).","journal-title":"Science"},{"key":"57627_CR13","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1126\/science.aan6733","volume":"357","author":"DT Le","year":"2017","unstructured":"Le, D. T. et al. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science 357, 409\u2013413, https:\/\/doi.org\/10.1126\/science.aan6733 (2017).","journal-title":"Science"},{"key":"57627_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03730-x","volume":"9","author":"DJ McGrail","year":"2018","unstructured":"McGrail, D. J. et al. Multi-omics analysis reveals neoantigen-independent immune cell infiltration in copy-number driven cancers. Nat. Commun. 9, 1317, https:\/\/doi.org\/10.1038\/s41467-018-03730-x (2018).","journal-title":"Nat. Commun."},{"key":"57627_CR15","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1038\/s41467-017-01018-0","volume":"8","author":"C-Y Ock","year":"2017","unstructured":"Ock, C.-Y. et al. Genomic landscape associated with potential response to anti-CTLA-4 treatment in cancers. Nature. Communications 8, 1050, https:\/\/doi.org\/10.1038\/s41467-017-01018-0 (2017).","journal-title":"Communications"},{"key":"57627_CR16","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","volume":"48","author":"V Thorsson","year":"2018","unstructured":"Thorsson, V. et al. The Immune Landscape of Cancer. Immunity 48, 812\u2013830 e814, https:\/\/doi.org\/10.1016\/j.immuni.2018.03.023 (2018).","journal-title":"Immunity"},{"key":"57627_CR17","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1158\/0008-5472.CAN-16-2490","volume":"77","author":"FS Varn","year":"2017","unstructured":"Varn, F. S., Wang, Y., Mullins, D. W., Fiering, S. & Cheng, C. Systematic Pan-Cancer Analysis Reveals Immune Cell Interactions in the Tumor Microenvironment. Cancer Res. 77, 1271\u20131282, https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-2490 (2017).","journal-title":"Cancer Res."},{"key":"57627_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-14-469","volume":"14","author":"TN Doig","year":"2013","unstructured":"Doig, T. N. et al. Coexpression analysis of large cancer datasets provides insight into the cellular phenotypes of the tumour microenvironment. BMC Genomics 14, 469, https:\/\/doi.org\/10.1186\/1471-2164-14-469 (2013).","journal-title":"BMC Genomics"},{"key":"57627_CR19","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nri3920","volume":"15","author":"Y Lavin","year":"2015","unstructured":"Lavin, Y., Mortha, A., Rahman, A. & Merad, M. Regulation of macrophage development and function in peripheral tissues. Nat. Rev. Immunology 15, 731\u2013744, https:\/\/doi.org\/10.1038\/nri3920 (2015).","journal-title":"Nat. Rev. Immunology"},{"key":"57627_CR20","doi-asserted-by":"publisher","unstructured":"Cancer Genome Atlas Research Network. Electronic address, e. d. s. c. & Cancer Genome Atlas Research, N. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell., 171, 950\u2013965 e928, https:\/\/doi.org\/10.1016\/j.cell.2017.10.014 (2017).","DOI":"10.1016\/j.cell.2017.10.014"},{"key":"57627_CR21","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.1002\/cncr.30738","volume":"123","author":"E Ben-Ami","year":"2017","unstructured":"Ben-Ami, E. et al. Immunotherapy with single agent nivolumab for advanced leiomyosarcoma of the uterus: Results of a phase 2 study. Cancer 123, 3285\u20133290, https:\/\/doi.org\/10.1002\/cncr.30738 (2017).","journal-title":"Cancer"},{"key":"57627_CR22","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.immuni.2017.02.001","volume":"46","author":"S George","year":"2017","unstructured":"George, S. et al. Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma. Immunity 46, 197\u2013204, https:\/\/doi.org\/10.1016\/j.immuni.2017.02.001 (2017).","journal-title":"Immunity"},{"key":"57627_CR23","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1001\/jamaoncol.2017.1617","volume":"4","author":"M Toulmonde","year":"2018","unstructured":"Toulmonde, M. et al. Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas: A Phase 2 Clinical Trial. JAMA Oncol. 4, 93\u201397, https:\/\/doi.org\/10.1001\/jamaoncol.2017.1617 (2018).","journal-title":"JAMA Oncol."},{"key":"57627_CR24","doi-asserted-by":"publisher","unstructured":"Cattoretti, G., Bosisio, F. M., Marcelis, L. & Bolognesi, M. M. Multiple Iteractive Labeling by Antibody Neodeposition (MILAN) Protocol Exchange, https:\/\/doi.org\/10.1038\/protex.2018.106 (2018).","DOI":"10.1038\/protex.2018.106"},{"key":"57627_CR25","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1369\/0022155417719419","volume":"65","author":"MM Bolognesi","year":"2017","unstructured":"Bolognesi, M. M. et al. Multiplex Staining by Sequential Immunostaining and Antibody Removal on Routine Tissue Sections. J. Histochemistry & Cytochemistry 65, 431\u2013444, https:\/\/doi.org\/10.1369\/0022155417719419 (2017).","journal-title":"J. Histochemistry & Cytochemistry"},{"key":"57627_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2006-7-10-r100","volume":"7","author":"AE Carpenter","year":"2006","unstructured":"Carpenter, A. E. et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol. 7, R100, https:\/\/doi.org\/10.1186\/gb-2006-7-10-r100 (2006).","journal-title":"Genome Biol."},{"key":"57627_CR27","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/nmeth.4391","volume":"14","author":"D Schapiro","year":"2017","unstructured":"Schapiro, D. et al. histoCAT: analysis of cell phenotypes and interactions in multiplex image cytometry data. Nat. methods 14, 873\u2013876, https:\/\/doi.org\/10.1038\/nmeth.4391 (2017).","journal-title":"Nat. methods"},{"key":"57627_CR28","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1111\/cas.13560","volume":"109","author":"A Seeber","year":"2018","unstructured":"Seeber, A. et al. High IDO-1 expression in tumor endothelial cells is associated with response to immunotherapy in metastatic renal cell carcinoma. Cancer Sci. 109, 1583\u20131591, https:\/\/doi.org\/10.1111\/cas.13560 (2018).","journal-title":"Cancer Sci."},{"key":"57627_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06653-9","volume":"9","author":"CA Egelston","year":"2018","unstructured":"Egelston, C. A. et al. Human breast tumor-infiltrating CD8+ T cells retain polyfunctionality despite PD-1 expression. Nat. Commun. 9, 4297, https:\/\/doi.org\/10.1038\/s41467-018-06653-9 (2018).","journal-title":"Nat. Commun."},{"key":"57627_CR30","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.cell.2018.05.060","volume":"174","author":"E Azizi","year":"2018","unstructured":"Azizi, E. et al. Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment. Cell. 174, 1293\u20131308.e1236, https:\/\/doi.org\/10.1016\/j.cell.2018.05.060 (2018).","journal-title":"Cell"},{"key":"57627_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05072-0","volume":"9","author":"T Duhen","year":"2018","unstructured":"Duhen, T. et al. Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors. Nat. Commun. 9, 2724, https:\/\/doi.org\/10.1038\/s41467-018-05072-0 (2018).","journal-title":"Nat. Commun."},{"key":"57627_CR32","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-018-0130-2","volume":"557","author":"Y Simoni","year":"2018","unstructured":"Simoni, Y. et al. Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates. Nat. Publ. Group. 557, 575\u2013579, https:\/\/doi.org\/10.1038\/s41586-018-0130-2 (2018).","journal-title":"Nat. Publ. Group."},{"key":"57627_CR33","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.cell.2018.10.038","volume":"175","author":"M Sade-Feldman","year":"2018","unstructured":"Sade-Feldman, M. et al. Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma. Cell. 175, 998\u20131013.e1020, https:\/\/doi.org\/10.1016\/j.cell.2018.10.038 (2018).","journal-title":"Cell"},{"key":"57627_CR34","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.ccell.2018.03.012","volume":"33","author":"DS Thommen","year":"2018","unstructured":"Thommen, D. S. & Schumacher, T. N. T Cell Dysfunction in Cancer. Cancer Cell. 33, 547\u2013562, https:\/\/doi.org\/10.1016\/j.ccell.2018.03.012 (2018).","journal-title":"Cancer Cell"},{"key":"57627_CR35","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/nm.4086","volume":"22","author":"T Saito","year":"2016","unstructured":"Saito, T. et al. Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers. Nat. Med. 22, 679\u2013684, https:\/\/doi.org\/10.1038\/nm.4086 (2016).","journal-title":"Nat. Med."},{"key":"57627_CR36","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.cell.2017.07.025","volume":"170","author":"A Jim\u00e9nez-S\u00e1nchez","year":"2017","unstructured":"Jim\u00e9nez-S\u00e1nchez, A. et al. Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient. Cell. 170, 927\u2013938.e920, https:\/\/doi.org\/10.1016\/j.cell.2017.07.025 (2017).","journal-title":"Cell"},{"key":"57627_CR37","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41591-018-0266-5","volume":"25","author":"W Scheper","year":"2019","unstructured":"Scheper, W. et al. Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers. Nat. Med. 25, 89\u201394, https:\/\/doi.org\/10.1038\/s41591-018-0266-5 (2019).","journal-title":"Nat. Med."},{"key":"57627_CR38","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.1252510","volume":"344","author":"RA Franklin","year":"2014","unstructured":"Franklin, R. A. et al. The cellular and molecular origin of tumor-associated macrophages. Science 344, 921\u2013925, https:\/\/doi.org\/10.1126\/science.1252510 (2014).","journal-title":"Science"},{"key":"57627_CR39","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s00281-013-0367-7","volume":"35","author":"SK Biswas","year":"2013","unstructured":"Biswas, S. K., Allavena, P. & Mantovani, A. Tumor-associated macrophages: functional diversity, clinical significance, and open questions. Semin. immunopathology 35, 585\u2013600, https:\/\/doi.org\/10.1007\/s00281-013-0367-7 (2013).","journal-title":"Semin. immunopathology"},{"key":"57627_CR40","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/nri3088","volume":"11","author":"T Lawrence","year":"2011","unstructured":"Lawrence, T. & Natoli, G. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat. Rev. Immunology 11, 750\u2013761, https:\/\/doi.org\/10.1038\/nri3088 (2011).","journal-title":"Nat. Rev. Immunology"},{"key":"57627_CR41","doi-asserted-by":"publisher","first-page":"eaat1500","DOI":"10.1126\/scitranslmed.aat1500","volume":"11","author":"S Singhal","year":"2019","unstructured":"Singhal, S. et al. Human tumor-associated monocytes\/macrophages and their regulation of T cell responses in early-stage lung cancer. Sci. Transl. Med. 11, eaat1500, https:\/\/doi.org\/10.1126\/scitranslmed.aat1500 (2019).","journal-title":"Sci. Transl. Med."},{"key":"57627_CR42","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/nri2448","volume":"8","author":"DM Mosser","year":"2008","unstructured":"Mosser, D. M. & Edwards, J. P. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunology 8, 958\u2013969, https:\/\/doi.org\/10.1038\/nri2448 (2008).","journal-title":"Nat. Rev. Immunology"},{"key":"57627_CR43","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.immuni.2014.01.006","volume":"40","author":"J Xue","year":"2014","unstructured":"Xue, J. et al. Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity 40, 274\u2013288, https:\/\/doi.org\/10.1016\/j.immuni.2014.01.006 (2014).","journal-title":"Immunity"},{"key":"57627_CR44","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1002\/ijc.25609","volume":"128","author":"G Sconocchia","year":"2011","unstructured":"Sconocchia, G. et al. Tumor infiltration by Fc\u03b3RIII (CD16)+ myeloid cells is associated with improved survival in patients with colorectal carcinoma. Int. J. cancer J. Int. du. cancer 128, 2663\u20132672, https:\/\/doi.org\/10.1002\/ijc.25609 (2011).","journal-title":"Int. J. cancer J. Int. du. cancer"},{"key":"57627_CR45","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature22396","volume":"545","author":"SR Gordon","year":"2017","unstructured":"Gordon, S. R. et al. PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity. Nature 545, 495\u2013499, https:\/\/doi.org\/10.1038\/nature22396 (2017).","journal-title":"Nature"},{"key":"57627_CR46","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1093\/intimm\/dxs098","volume":"25","author":"M-L Thibult","year":"2013","unstructured":"Thibult, M.-L. et al. PD-1 is a novel regulator of human B-cell activation. Int. immunology 25, 129\u2013137, https:\/\/doi.org\/10.1093\/intimm\/dxs098 (2013).","journal-title":"Int. immunology"},{"key":"57627_CR47","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1158\/2326-6066.CIR-17-0537","volume":"6","author":"GP Hartley","year":"2018","unstructured":"Hartley, G. P., Chow, L., Ammons, D. T., Wheat, W. H. & Dow, S. W. Programmed Cell Death Ligand 1 (PD-L1) Signaling Regulates Macrophage Proliferation and Activation. Cancer immunology Res. 6, 1260\u20131273, https:\/\/doi.org\/10.1158\/2326-6066.CIR-17-0537 (2018).","journal-title":"Cancer immunology Res."},{"key":"57627_CR48","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nm.4308","volume":"23","author":"J Gao","year":"2017","unstructured":"Gao, J. et al. VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer. Nat. Med. 23, 551\u2013555, https:\/\/doi.org\/10.1038\/nm.4308 (2017).","journal-title":"Nat. Med."},{"key":"57627_CR49","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1073\/pnas.0306407101","volume":"101","author":"MJ Miller","year":"2004","unstructured":"Miller, M. J., Hejazi, A. S., Wei, S. H., Cahalan, M. D. & Parker, I. T cell repertoire scanning is promoted by dynamic dendritic cell behavior and random T cell motility in the lymph node. Proc. Natl. Acad. Sci. USA 101, 998\u20131003, https:\/\/doi.org\/10.1073\/pnas.0306407101 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"}],"updated-by":[{"DOI":"10.1038\/s41598-021-95855-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T00:00:00Z","timestamp":1628121600000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-57627-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-57627-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-57627-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T05:52:40Z","timestamp":1670305960000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-57627-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,20]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["57627"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-57627-1","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41598-021-95855-1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,20]]},"assertion":[{"value":"27 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-021-95855-1","URL":"https:\/\/doi.org\/10.1038\/s41598-021-95855-1","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"702"}}